Skip to content

Hyperinsulinemic Hypoglycemia With Polycystic Kidney Disease Cn377840

Published: July 22, 2026Updated: August 20, 2026

A rare condition combining low blood sugar from excess insulin with polycystic kidney disease. It affects multiple organs and requires careful monitoring. Treatment includes dietary management and kidney function surveillance.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Diazoxide

Potassium channel activator that suppresses insulin secretion from pancreatic beta cells, helping manage hyperinsulinemic hypoglycemia by preventing inappropriate insulin release.

medication
2

Endocrine management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Complex Carbohydrate Diet with Frequent Feeding

Structured feeding schedule with slow-digesting carbohydrates maintains stable glucose levels and reduces hypoglycemic episodes throughout the day.

dietary

Additional treatment options

Pancreatectomy

Surgical removal of abnormal pancreatic tissue may be considered in focal disease or refractory cases unresponsive to medical management.

procedure

Continuous Glucose Monitoring

Real-time glucose tracking enables early detection of hypoglycemic episodes and guides dietary and medication adjustments for optimal metabolic control.

monitoring

Everolimus

mTOR inhibitor may be considered off-label for refractory hyperinsulinism, particularly in patients with associated renal involvement, as it affects pancreatic beta cell proliferation.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hyperinsulinemic Hypoglycemia With Polycystic Kidney Disease Cn377840?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Hyperinsulinemic Hypoglycemia With Polycystic Kidney Disease Cn377840. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy